AI assistant
Sending…
TALPHERA, INC. — Director's Dealing 2013
Sep 16, 2013
35181_dirs_2013-09-16_7fd8aaf2-2e49-40f6-8514-91aa2a4d2f03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2013-09-12
Reporting Person: Chung David (Chief Commercial Officer)
More from TALPHERA, INC.
Interim / Quarterly Report
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 29
Director's Dealing
2026
Mar 26
Earnings Release
2026
Mar 23
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Major Shareholding Notification
2026
Feb 17